These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2884120)

  • 1. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system.
    Johnson M; Stone DM; Hanson GR; Gibb JW
    Eur J Pharmacol; 1987 Mar; 135(2):231-4. PubMed ID: 2884120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal substantia nigra grafts. Effect on dopamine receptors in the rat corpus striatium.
    Korfali E; Knowles WD; Uysal S; Ulus IH; Ozmen T
    Cleve Clin J Med; 1989 May; 56(3):259-62. PubMed ID: 2568188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system.
    Sonsalla PK; Gibb JW; Hanson GR
    Neuropharmacology; 1986 Nov; 25(11):1221-30. PubMed ID: 2432440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues.
    Dunnett SB; Hernandez TD; Summerfield A; Jones GH; Arbuthnott G
    Exp Brain Res; 1988; 71(2):411-24. PubMed ID: 2901978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway.
    Nishino H; Hashitani T; Kumazaki M; Sato H; Furuyama F; Isobe Y; Watari N; Kanai M; Shiosaka S
    Brain Res; 1990 Nov; 534(1-2):83-93. PubMed ID: 1981488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigrostriatal reconstruction after 6-OHDA lesions in rats: combination of dopamine-rich nigral grafts and nigrostriatal "bridge" grafts.
    Dunnett SB; Rogers DC; Richards SJ
    Exp Brain Res; 1989; 75(3):523-35. PubMed ID: 2568267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal dopamine-rich grafts and 6-OHDA lesions independently provide partial protection from the adult nigrostriatal lesion syndrome.
    Rogers DC; Dunnett SB
    Behav Brain Res; 1989 Aug; 34(1-2):131-46. PubMed ID: 2504223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats.
    Marek GJ; Vosmer G; Seiden LS
    Pharmacol Biochem Behav; 1990 May; 36(1):187-90. PubMed ID: 2112259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
    Kogan FJ; Nichols WK; Gibb JW
    Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
    Marek GJ; Vosmer G; Seiden LS
    Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.
    Hotchkiss AJ; Gibb JW
    J Pharmacol Exp Ther; 1980 Aug; 214(2):257-62. PubMed ID: 6104722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
    Schmidt CJ; Gibb JW
    Eur J Pharmacol; 1985 Feb; 109(1):73-80. PubMed ID: 2581794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
    Melamed E; Hefti F; Wurtman RJ
    Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesions.
    Walker PD; Riley LA; Hart RP; Jonakait GM
    Brain Res; 1991 Aug; 557(1-2):31-6. PubMed ID: 1720996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system.
    Venero JL; Romero-Ramos M; Revuelta M; Machado A; Cano J
    Brain Res; 1995 Feb; 672(1-2):153-8. PubMed ID: 7749737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.